American Heart Journal
Volume 156, Issue 2 , Pages 315-321 , August 2008

Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α1-adrenoreceptor signal transduction

  • Benjamin W. Van Tassell, PharmD, BCPS

      Affiliations

    • Department of Pharmacotherapy, University of Utah, Salt Lake City, UT
    • Corresponding Author InformationReprint requests: Benjamin W. Van Tassell, PharmD, BCPS, University of Utah, 30 South, 2000 East, Rm #258, Salt Lake City, UT 84112.
  • ,
  • Matthew T. Rondina, MD

      Affiliations

    • Department of Medicine, University of Utah, Salt Lake City, UT
  • ,
  • Franklin Huggins, PharmD

      Affiliations

    • Department of Pharmacotherapy, University of Utah, Salt Lake City, UT
  • ,
  • Edward M. Gilbert, MD

      Affiliations

    • Department of Medicine, University of Utah, Salt Lake City, UT
  • ,
  • Mark A. Munger, PharmD, FCCP

      Affiliations

    • Department of Pharmacotherapy, University of Utah, Salt Lake City, UT
    • Department of Medicine, University of Utah, Salt Lake City, UT

Received 12 February 2008 ,Accepted 1 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: GlaxoSmithKline Investigator Initiated Trials.

 Conflict of interest: Benjamin W. Van Tassell, none; Matthew Rondina, none; Franklin Huggins, none; Mark A. Munger, GlaxoSmithKline Speakers Bureau and Research Grant Support; Edward M. Gilbert, GlaxoSmithKline Speakers Bureau and Research Grant Support.

PII: S0002-8703(08)00279-2

doi: 10.1016/j.ahj.2008.04.004

American Heart Journal
Volume 156, Issue 2 , Pages 315-321 , August 2008